These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7414765)

  • 41. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
    Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
    J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic evaluation of urolithiasis patients from eastern Croatia.
    Babić-Ivancić V; Avdagić SC; Serić V; Kontrec J; Tucak A; Füredi-Milhofer H; Marković M
    Coll Antropol; 2004 Dec; 28(2):655-66. PubMed ID: 15666597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
    J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystallization kinetics of calcium oxalate in fresh, minimally diluted urine: comparison of recurrent stone formers and healthy controls in a continuous mixed suspension mixed product removal crystallizer.
    Kavanagh JP; Nishio S; Garside J; Blacklock NJ
    J Urol; 1993 Mar; 149(3):614-7. PubMed ID: 8437278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers.
    Tsujihata M; Tsujikawa K; Tei N; Yoshimura K; Okuyama A
    Int J Urol; 2006 Mar; 13(3):197-201. PubMed ID: 16643608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased risk of urinary stone disease by physical exercise.
    Sriboonlue P; Prasongwatana V; Tosukhowong P; Tungsanga K; Bovornpadoongkitti S
    Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):172-7. PubMed ID: 9031423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary Tamm-Horsfall protein and citrate: a case-control study of inhibitors and promoters of calcium stone formation.
    Pourmand G; Nasseh H; Sarrafnejad A; Mehrsai A; Hamidi Alamdari D; Nourijelyani K; Shekarpour L
    Urol J; 2005; 2(2):79-85. PubMed ID: 17629875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of pH on urinary ionized [Ca2+]: differences between urinary tract stone formers and normal subjects.
    Langley SE; Fry CH
    Br J Urol; 1997 Jan; 79(1):8-14. PubMed ID: 9043487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Idiopathic hypercalciuria. Urate and other ions in urine before and on various long term treatments.
    Gill HS; Rose GA
    Urol Res; 1985; 13(6):271-5. PubMed ID: 4095826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relationship of the urinary cations, Calcium, Magnesium, Sodium and Potassium, in patients with Renal Calculi.
    Welshman SG; McGeown MG
    Br J Urol; 1975 Jun; 47(3):237-42. PubMed ID: 1139114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of pyridoxine supplementation on recurrent stone formers.
    Murthy MS; Farooqui S; Talwar HS; Thind SK; Nath R; Rajendran L; Bapna BC
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):434-7. PubMed ID: 7141762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Urinary calcium and phosphorus excretion and their relationship in calcium-containing urinary stone formers].
    Kitamura T; Moriyama N; Kawabe K; Aso Y
    Nihon Hinyokika Gakkai Zasshi; 1989 Feb; 80(2):197-203. PubMed ID: 2747084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between 1,25-dihydroxyvitamin-D, calcium and uric acid in urinary stone formers.
    Jarrar K; Amasheh RA; Graef V; Weidner W
    Urol Int; 1996; 56(1):16-20. PubMed ID: 8903548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in the free Ca2+ in undiluted urine from stone formers and normal subjects using a new generation of ion-selective electrodes.
    Langley SE; Fry CH
    Br J Urol; 1995 Mar; 75(3):288-95. PubMed ID: 7735795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Estimation of the concentration of urinary ionic calcium and its clinical role in urolithiasis].
    Minakata S
    Nihon Hinyokika Gakkai Zasshi; 1990 Dec; 81(12):1896-903. PubMed ID: 2292824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Guidelines for prevention of recurrent urolithiasis (author's transl)].
    Zechner O
    Wien Klin Wochenschr; 1981 Oct; 93(20):619-24. PubMed ID: 7324473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Calcium-binding anions in urine of patients with recurrent calculi and in healthy controls. Results of a long-term study].
    Leskovar P
    Z Urol Nephrol; 1982 Sep; 75(9):635-44. PubMed ID: 7158097
    [No Abstract]   [Full Text] [Related]  

  • 60. Urolithiasis in the Sudan. Studies on a stone-prone and a stone-free population.
    Kambal A; Wahab EM; Khattab AH; Zaki J
    Br J Urol; 1981 Feb; 53(1):7-12. PubMed ID: 7470805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.